Yves Decadt

Yves Decadt

Chief Executive Officer at BioLingus (Cayman) Ltd.

57 year
Health Technology
Consumer Services
Retail Trade

Profile

Yves Decadt is the founder and currently serves as Chairman & Chief Executive Officer of BioLingus (Cayman) Ltd.
He previously held the position of Chief Executive Officer at Stragen Pharma SA. From 2015 to 2017, he was the Chief Executive Officer of MEDIMETRICS Personalized Drug Delivery BV.
Prior to that, he served as Director-Licensing & New Business Development at Johnson & Johnson and Johnson & Johnson AG from 2005 to 2010.
He also held the position of Vice President-Business Development at SkyePharma AG.
Mr. Decadt received his graduate degree from Ghent University and Université Libre de Bruxelles.
Mr. Decadt founded BioLingus (Cayman) Ltd.
in 2018.

Yves Decadt active positions

CompaniesPositionStart
Chief Executive Officer 08/08/2018
All active positions of Yves Decadt

Former positions of Yves Decadt

CompaniesPositionEnd
Chief Executive Officer 01/06/2017
JOHNSON & JOHNSON Corporate Officer/Principal 01/07/2010
Corporate Officer/Principal 01/07/2010
SkyePharma AG Corporate Officer/Principal -
Chief Executive Officer -
See the detail of Yves Decadt's experience

Training of Yves Decadt

Ghent University Graduate Degree
Université Libre de Bruxelles Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yves Decadt's experience

Connections

99

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
JOHNSON & JOHNSON

Health Technology

Private companies5
SkyePharma AG

Health Technology

Health Technology

Retail Trade

Commercial Services

See company connections